Thank you very much, Mr. Chair, and thank you very much for the leadership you've been providing for a very important file for all Canadians. It's great to have you as our Minister of Health.
My first question is around the opioid crisis that we've been dealing with, and fentanyl. It is wonderful in Bill C-37 to see a return to evidence-based harm reduction approaches to this crisis, which is a big change from what we had in place before. So with Bill C-37 coming forward, can you tell the committee, are we seeing easier access to safe consumption sites, and are we starting to see prescription changes in naloxone availability? Are you sensing a turn here?